Articles related to Immunotherapy

lung-cancer-research-640.jpg

Moffitt’s Top Research Developments of 2017: Novel Combination Approach to Lung Cancer Wins Moffitt a Stand Up To Cancer Grant

The second one on the list of Moffitt research developments involves a grant to study how immunotherapy can change the way the cancer center is treating lung cancer. Read More


Locke-research-lab.jpg

Moffitt’s Top Research Developments of 2017: CAR T Therapy Tested, Commercially Available at Moffitt

The first one on the list of Moffitt's top research developments for 2017 is the FDA approval of CAR T therapy for certain aggressive types of adult lymphoma. Read More


CART-Cell-Illustration-640.jpg

Moffitt Treats First U.S. Patient with Newly FDA-Approved CAR T Therapy

Moffitt has treated the first U.S. adult lymphoma patient with a therapy formerly available only through clinical trials. Read More


CART-teaser.jpeg

Infographic: How CAR T Therapy Works to Fight Cancer

CAR T therapy, a groundbreaking new treatment, utilizes the body’s own immune system to fight cancer. Read More


CART-lab-640.jpg

What is CAR T Therapy?

Dr. Frederick Locke, vice chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy, answers some frequently asked questions about CAR T cell therapy. Read More


DrFredLocke-CART-640.jpg

CAR T Cancer Therapy a ‘Huge Breakthrough’ for Patients with Lymphoma

Moffitt patients with an aggressive type of lymphoma were among the first to benefit in clinical trials of a groundbreaking therapy. Read More


Abate-Daga-Spotlight-640.jpg

Research Spotlight: Dr. Abate-Daga Discusses the Progress of Immunotherapy

Dr. Daniel Abate-Daga's research is focused on the development of T cell-based immunotherapies for the treatment of cancer. Read More


Locke-blog.jpg

Dr. Locke: CAR-T Cell Therapy a 'Revolution in Cancer Care'

Dr. Locke, the principal investigator for a new experimental immunotherapy called CAR T-cell therapy, talks about the breakthroughs with this type of treatment. Read More